SAM
AXSM icon

Smartleaf Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Smartleaf Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.7K Sell
316
-58
-16% -$10K ﹤0.01% 1443
2025
Q4 		$55.6K Buy
374
+175
+88% +$24.4K ﹤0.01% 1493
2025
Q3 		$23.4K Buy
199
+84
+73% +$9.46K ﹤0.01% 1747
2025
Q2 		$11.9K Sell
115
-74
-39% -$7.84K ﹤0.01% 1767
2025
Q1 		$22.4K Buy
189
+7
+4% +$797 ﹤0.01% 1555
2024
Q4 		$15.4K Buy
182
+105
+136% +$9.66K ﹤0.01% 1792
2024
Q3 		$6.9K Buy
77
+22
+40% +$1.92K ﹤0.01% 1973
2024
Q2 		$4.4K Buy
+55
New +$4.07K ﹤0.01% 1861

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Smartleaf Asset Management's AXSM Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Axsome Therapeutics (AXSM) stake by 16% in Q1 2026, selling an estimated $10K and leaving 316 shares worth $50.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1443.

Smartleaf Asset Management first reported a position in AXSM in Q2 2024 and has held it in 8 quarters since. The position peaked at $55.6K in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Smartleaf Asset Management held 316 shares of Axsome Therapeutics worth $50.7K as of Q1 2026.
  • Smartleaf Asset Management sold 58 Axsome Therapeutics shares in Q1 2026, an estimated $10K.
  • Axsome Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #1443 holding.
  • Smartleaf Asset Management first reported a position in Axsome Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's Axsome Therapeutics position peaked at $55.6K in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.